000 Americans each consume a lot more than $50.

Everything from pain supplements to psychiatric medicines to cancer poisons make up what the report found to represent a 63 % upsurge in pharmaceutical drug use compared to 2013 figures. The majority of the sufferers in this category were found to be acquiring specialty medicines, having multiple co-morbidities, prescriptions, and prescribers. Nine out of 10 individuals in the high-cost category take medications for multiple conditions, in fact, including drugs for circumstances like high blood circulation pressure, raised chlesterol, diabetes, and depression. Antidepressant use within this category was exceptionally high, representing twice the use rate compared to the general population. Shockingly, six in 10 patients in the high-cost medication category were found to be taking 10 or even more different medications at one time, with 72 % acquiring written prescriptions from at least four different prescribers.But that move might not be enough, as the publisher Hindawi found out this past springtime. Although Hindawi doesn’t let authors recommend reviewers because of their manuscripts, it decided to examine the peer-review information for manuscripts submitted in 2013 and 2014 for possible fraud. The peer-review procedure found in Hindawi’s journals depends primarily on the expertise of its editorial board members and the guest editors of special issues, who are responsible for supervising the overview of submitted manuscripts.5 Since the peer reviewers selected by the guest editors weren’t subject to any kind of independent verification, editors themselves could undermine the procedure in quite similar way that authors or third-party agencies have done elsewhere: by creating fake reviewer identities and addresses that they submitted reviews that are positive endorsing publication.